Biography:
Since 2022, Amin has worked as a clinician at Sankt Erik Eye Hospital, focusing on glaucoma and neuro-ophthalmology. He earned a Master’s in Immunology and Development from Aix-Marseille University in 2012 and conducted research on genomic instability in hemopathies at Harvard Medical School and Karolinska Institutet. After completing his Medical degree in 2018, he joined the Pete Williams Lab in 2019 to study mitochondrial and metabolic changes in glaucoma, exploring novel therapeutic approaches. Now pursuing a PhD, Amin combines clinical practice with research, aiming to advance glaucoma understanding and treatment through innovation and international collaboration.
Title : Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume